Evidence map›Paper›PMID 32266221›Full record

ReviewFrontiers in bioengineering and biotechnology2020

Tissue Engineering and Regenerative Medicine: Achievements, Future, and Sustainability in Asia.

Fengxuan Han, Jiayuan Wang, Luguang Ding, Yuanbin Hu, Wenquan Li, Zhangqin Yuan, Qianping Guo, Caihong Zhu, Li Yu, Huan Wang and 8 more

Abstract readReview
In one paragraph

Review in Frontiers in bioengineering and biotechnology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 126 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
126citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

126 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review

66 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Fengxuan HanDepartment of Orthopaedic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.
Jiayuan WangDepartment of Orthopaedic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.
Luguang DingDepartment of Orthopaedic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.
Yuanbin HuDepartment of Orthopaedics, Zhongda Hospital, Southeast University, Nanjing, China.
Wenquan LiDepartment of Otolaryngology, The Second Affiliated Hospital of Soochow University, Suzhou, China.
Zhangqin YuanDepartment of Orthopaedic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.
Qianping GuoDepartment of Orthopaedic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.
Caihong ZhuDepartment of Orthopaedic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.
Li YuDepartment of Orthopaedic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.
Huan WangDepartment of Orthopaedic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.
Zhongliang ZhaoDepartment of Orthopaedic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.
Luanluan JiaDepartment of Orthopaedic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.
Jiaying LiDepartment of Orthopaedic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.
Yingkang YuDepartment of Orthopaedic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.
Weidong ZhangDepartment of Orthopaedic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.
Genglei ChuDepartment of Orthopaedic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.
Song ChenDepartment of Orthopaedic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.
Bin LiDepartment of Orthopaedic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Exploring innovative solutions to improve the healthcare of the aging and diseased population continues to be a global challenge. Among a number of strategies toward this goal, tissue engineering and regenerative medicine (TERM) has gradually evolved into a promising approach to meet future needs of patients. TERM has recently received increasing attention in Asia, as evidenced by the markedly increased number of researchers, publications, clinical trials, and translational products. This review aims to give a brief overview of TERM development in Asia over the last decade by highlighting some of the important advances in this field and featuring major achievements of representative research groups. The development of novel biomaterials and enabling technologies, identification of new cell sources, and applications of TERM in various tissues are briefly introduced. Finally, the achievement of TERM in Asia, including important publications, representative discoveries, clinical trials, and examples of commercial products will be introduced. Discussion on current limitations and future directions in this hot topic will also be provided.

Indexed as

Asiabiomaterialsbiomechanicscell sourcesregenerative medicinetissue engineering

Identifiers

PMID32266221
PMCPMC7105900

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.